The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 3 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Wegovy and Ozempic cost over $1,000 monthly in the United States
“The price of Ozempic to treat diabetes is north of a thousand dollars, and Wegovy for weight loss is north of 1300 dollars per month before insurance, and this is in the U.S.
So expensive, right?
That's a lot of money.
In Canada, of course, Ozempic is 147 doll…”
Massive GLP-1 demand will enable multiple pharma hits like insulin
“I think this is going to be like insulin all over again, where there's just going to be a series of product improvements and companies will drive innovation and increase supply. I mean, the demand is so huge out there that Monroe can be a huge hit. Ozempic and…”
Wegovy matched Saxenda's lifetime United States doctor prescriptions in one month
“So when Wegevee finally launches in the U.S. In 2021 as the official FDA sanctioned weight loss version of semaglutide, it gets the same number of prescriptions written for it by doctors. In the first slightly over one month than Saxenda had in its entire drug…”